Publications by authors named "Jm Peron"

Claim this Profile
F
Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective Study.
Lucy Meunier, Bénédicte Delire, Eleonora De Martin, Fanny Lebossé, Rodolphe Anty

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, Ethan Neumann, Waqar Arif, Jean-Marie Peron

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study.
François Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, Jean-Marie Péron, Marilyne Debette-Gratien

Liver Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.
Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo, Mohamed Bouattour, Julien Edeline, Jean Marie Peron

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma.
Anaïs Lopez, Alexia Paturel, Nadim Fares, Floriane Pez, Guanxiong Wang, Jean-Marie Peron

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, Amaddeo Giuliana, Thomas Decaens, Jean-Marie Peron

Eur J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial.
George Lau, Bruno Sangro, Ann-Lii Cheng, Masatoshi Kudo, Robin Kate Kelley, Jean-Marie Peron

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities.
Ludovic Hernandez, Laure Parent, Victoire Molinier, Bertrand Suc, Françoise Izar, Jean-Marie Peron

Clin Transl Radiat Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Bruno Sangro, Masatoshi Kudo, Joseph P Erinjeri, Shukui Qin, Zhenggang Ren, Jean-Marie Peron

Lancet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List.
Hugues Radovitch, Sarah Le Sagere, Bastien Cabarrou, Charlotte Maulat, Paul Boulard, Jean-Marie Peron

Transplant Proc· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an automated platform for the detection of HEV RNA in plasma and stool.
Pauline Sottil, Sébastien Lhomme, Karine Saune, Soheil El Hayani, Kévin Oliveira-Mendes, Jean-Marie Peron

J Virol Methods· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curative surgical treatment of common bile duct stones: Retrospective cohort study.
Julien Pouplin, Charlotte Maulat, Gabriel Yubero, Jason Shourick, Emmanuel Cuellar, Jean-Marie Peron

World J Surg· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified PSYCHE NMR - The possibility for the direct semi-quantitation of components in mixtures.
Arija Durrant, Jean-Marie R Peron, Moses K Langat, Cameron Robertson, Adam Le Gresley

Talanta· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort.
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, Hajer Ben Khadhra, Philippe Merle, Jean-Marie Peron

Eur J Gastroenterol Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pressing need for a global HEV vaccine.
Jean-Marie Peron, Hélène Larrue, Jacques Izopet, Maria Buti

J Hepatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.
Hélène Larrue, Gennaro D'Amico, Pol Olivas, Yong Lv, Theresa Bucsics

J Hepatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
Jean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, Thierry Thevenot, Honoré Zougmore, Jean-Marie Peron

BMC Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term expectant management of common bile duct stones in non-dilated common bile duct: retrospective cohort study.
Julien Pouplin, Charlotte Maulat, Gabriel Yubero, Jason Shourick, Emmanuel Cuellar, Jean-Marie Peron

BJS Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitors.
Vincent Haghnejad, Marie Muller, Lorraine Blaise, Rene Gerolami, Mohamed Bouattour, Jean-Marie Peron

Dig Liver Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial.
Philippe Merle, Jean-Frédéric Blanc, Julien Edeline, Karine Le Malicot, Manon Allaire

Dig Liver Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
Alix Demory, Jean-Marie Péron, Julien Calderaro, Janick Selves, Fatima-Zohra Mokrane

Hepatology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and management strategies for chronic hepatitis E infection.
Florence Abravanel, Sébastien Lhomme, Olivier Marion, Jean Marie Péron, Nassim Kamar

Expert Rev Anti Infect Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
Guillaume Le Cosquer, Anne Cécile Brunac, Jean Marie Peron

Gastroenterology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Isabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, Cendrine Chaffaut, Thông Dao, Jean-Marie Peron

Liver Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute kidney injury in patients with cirrhosis: Prospective longitudinal study in 405 patients.
Lucile Moga, Marie-Angèle Robic, Hélène Blasco-Perrin, Pauline Cabarrou, Julie Mogno

Clin Res Hepatol Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis